Journal of Natural Products
ARTICLE
Hydrogenation of Compound 8. Compound 8 (5 mg) was
hydrogenated with 10 mg of 10% Pd/C in pyridine (1 mL) at room
temperature and atmospheric pressure for 24 h. After the catalyst was
removed by filtration, the filtrate was concentrated to give a residue,
which was chromatographed on silica gel using n-hexaneꢀEtOAc (3:1)
as eluent to afford 8a (4 mg). The relative configuration was established
by analysis of NOE correlations observed in an NOESY experiment. CD
(1.9 ꢁ 10ꢀ4 M, MeOH) λmax (Δε) 290 (ꢀ0.35) and 215 (ꢀ2.04); 1H
NMR (CDCl3, 400 MHz) of 8a, δ 4.48 (1H, br d, J = 12.0 Hz, H-22),
4.25 (1H, d, J = 12.0 Hz, H-18a), 3.87 (1H, d, J = 12.0 Hz, H-18b), 2.71
(1H, m, H-25), 2.65 (1H, m, H-4a), 2.43 (1H, br d, J = 12.8 Hz, H-12a),
2.30 (1H, m, H-2a), 2.22 (1H, m, H-24), 2.20 (1H, m, H-2b), 2.08 (3H,
s, OCOCH3), 2.04 (2H, m, H-4b and H-20), 2.00 (1H, m, H-1a), 1.89
(1H, m, H-6a), 1.85 (1H, m, H-5), 1.79 (2H, m, H-16a and H-23a), 1.70
(1H, H-15a), 1.54 (1H, m, H-8), 1.53 (2H, m, H2-7), 1.52 (1H, m,
H-16b), 1.51 (1H, m, H-9), 1.50 (1H, m, H-11a), 1.40 (1H, m, H-1b),
1.37 (1H, m, H-23b), 1.30 (2H, m, H-11b and H-14), 1.27 (1H, m,
H-6b), 1.26 (1H, m, H-17), 1.16 (3H, d, J = 6.8 Hz, H3-27), 1.15 (2H, m,
H-12b, and H-15b), 1.08 (3H, d, J = 6.4 Hz, H3-21), 1.03 (3H, s, H3-19),
0.94 (3H, d, J = 6.4 Hz, H3-28); 13C NMR (CDCl3, 100 MHz) of 8a, δ
213.0 (C, C-3), 176.2 (C, C-26), 171.2 (C, OCOCH3), 79.8 (CH,
C-22), 62.3 (CH2, C-18), 55.6 (CH, C-14), 52.7 (CH, C-17), 45.9 (C,
C-13), 43.9 (CH, C-5), 42.2 (CH2, C-4), 41.0 (CH, C-9), 39.2 (CH,
C-20), 38.2 (CH, C-25), 37.1 (CH2, C-2), 36.8 (CH2, C-1), 35.7 (CH,
C-8), 35.1 (CH2, C-12), 34.8 (C, C-10), 29.2 (CH, C-24), 27.2 (CH2,
C-23), 27.1 (CH2, C-16), 26.4 (CH2, C-6), 25.9 (CH2, C-7), 24.0 (CH2,
C-15), 22.6 (CH3, C-19), 21.1 (CH3, OCOCH3), 21.0 (CH2, C-11),
18.2 (CH3, C-28), 12.9 (CH3, C-21), 12.1 (CH3, C-27); ESIMS m/z
509 [M þ Na]þ.
Preparation of (S)- and (R)-MTPA Esters of 4. To a solution of
4 (0.5 mg) in pyridine (0.4 mL) was added (R)-MTPA chloride (25 μL),
and the mixture was allowed to stand for 3 h at room temperature. The
reaction was quenched by the addition of H2O (1.0 mL), and the
mixture was subsequently extracted with EtOAc (3 ꢁ 1.0 mL). The
EtOAc-soluble layers were combined, dried over anhydrous MgSO4, and
evaporated. The residue was subjected to short silica gel column
chromatography using n-hexaneꢀacetone (5:1) to yield the (S)-MTPA
ester, 4a (0.4 mg). The same procedure was used to prepare the (R)-
MTPA ester, 4b (0.5 mg from 0.5 mg of 4), with (S)-MTPA chloride.
Selected 1H NMR (CDCl3, 300 MHz) of 4a: δ 7.380ꢀ7.600 (5H, m,
Ph), 7.031 (1H, d, J = 10.0 Hz, H-1), 6.228 (1H, d, J = 10.0 Hz, H-2),
6.072 (1H, s, H-4), 5.200 (1H, br d, J = 9.8 Hz, H-22), 4.409 (1H, dd, J =
9.8, 4.0 Hz, H-23), 3.526 (3H, s, OMe), 1.223 (3H, s, H3-19), 1.141 (3H,
d, J = 7.1 Hz, H3-27), 0.966 (3H, d, J = 6.8 Hz, H3-21), 0.772 (3H, d, J =
6.8 Hz, H3-28), 0.713 (3H, s, H3-18); ESIMS m/z 679 [M þ Na]þ. 1H
NMR (CDCl3, 300 MHz) of 4b: δ 7.380ꢀ7.600 (5H, m, Ph), 7.050
(1H, d, J = 10.0 Hz, H-1), 6.245 (1H, d, J = 10.0 Hz, H-2), 6.091 (1H, s,
H-4), 5.199 (1H, br d, J = 10.2 Hz, H-22), 4.374 (1H, dd, J = 10.2, 3.9 Hz,
H-23), 3.546 (3H, s, OMe), 1.225 (3H, s, H3-19), 1.107 (3H, d, J = 7.1
Hz, H3-27), 1.016 (3H, d, J = 6.8 Hz, H3-21), 0.727 (3H, s, H3-18), 0.696
(3H, d, J = 7.1 Hz, H3-28); ESIMS m/z 679 [M þ Na]þ.
Figure 6. Effect of compounds 1ꢀ5 and 7ꢀ11 at 10 μM on the LPS-
induced pro-inflammatory iNOS and on COX-2 protein expression of
RAW264.7 macrophage cells by immunoblot analysis. (A) Quantifica-
tion of immunoblots of iNOS. (B) Quantification of immunoblots of
COX-2. The values are means ( SEM (n = 6). The relative intensity of
the LPS alone stimulated group was taken as 100%. *Significantly
a
different from LPS alone stimulated group (*p < 0.05). Stimulated
with LPS. bStimulated with LPS in the presence of 1ꢀ5 and 7ꢀ11 (10
μM). (C) Quantification of immunoblots of β-actin.
[R(int) = 0.0277]; completeness to θmax was 97.4%; psi-scan absorption
correction applied; full-matrix least-squares refinement on F2, the
number of data/restraints/parameters were 3586/0/275; goodness-
of-fit on F2 = 1.046; final R indices [I > 2σ(I)], R1 = 0.0370 wR2 =
0.0886; R indices (all data), R1 = 0.0385, wR2 = 0.0894, largest difference
peak and hole, 0.198 and ꢀ0.175 e/Å3.
Crystallographic Data and X-ray Structure Analysis of 11.
A suitable colorless crystal (0.6 ꢁ 0.5 ꢁ 0.4 mm3) of 11 was grown by
slow evaporation from a MeOHꢀacetoneꢀn-hexane (1:3:10) solution.
Diffraction intensity data were acquired with a CCD area detector with
graphite-monochromated Mo KR radiation (λ = 0.71073 Å). Crystal
data for 11: C29H42O5 (formula weight 470.65), approximate crystal
size, 0.6 ꢁ 0.5 ꢁ 0.4 mm3, monoclinic, space group, P21 (#4), T =
150(2) K, a = 13.846(4) Å, b = 6.1634(17) Å, c = 15.497(4) Å, β =
105.886(15)ꢀ, V = 1272.1(6) Å3, Dc = 1.229 Mg/m3, Z = 2, F(000) =
512, μ(Mo KR) = 0.082 mmꢀ1. A total of 8917 reflections were
collected in the range 1.37ꢀ < θ < 25.16ꢀ, with 3933 independent
reflections [R(int) = 0.0170]; completeness to θmax was 98.8%; psi-scan
absorption correction applied; full-matrix least-squares refinement on
F2, the number of data/restraints/parameters were 3933/1/312; good-
ness-of-fit on F2 = 1.065; final R indices [I > 2σ(I)], R1 = 0.0285 wR2 =
0.0692; R indices (all data), R1 = 0.0301, wR2 = 0.0725, largest difference
peak and hole, 0.241 and ꢀ0.153 e/Å3.
Cytotoxicity Testing. Cell lines were purchased from the Amer-
ican Type Culture Collection (ATCC). Cytotoxicity assays were
performed using the MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl-
tetrazolium bromide] colorimetric method.19,20 Doxorubicin was em-
ployed as positive control, which exhibited cytotoxic activity toward
HepG2, Hep3B, MDA-MB-231, MCF-7, and A-549 cancer cell lines
with IC50 values of 0.5, 0.7, 2.2, 1.2, and 2.2 μM, respectively.
Compounds were considered to be inactive with IC50 values > 20
μM/mL.
In Vitro Anti-inflammatory Assay. Macrophage (RAW264.7)
cell line was purchased from ATCC. In vitro anti-inflammatory activity
of tested compounds was measured by examining the inhibition of
lipopolysaccharide (LPS)-induced upregulation of iNOS (inducible
1140
dx.doi.org/10.1021/np2000705 |J. Nat. Prod. 2011, 74, 1132–1141